ARCHIVES

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

September 10, 1976

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991

Advisory Council To Be Named For Alternative Medicine Cuts

May 27, 1994

NCI Community Intervention Trial Reports

March 10, 1995

Hammer Goes Public With Appeal for Increased Funding

March 14, 1986

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003